GSK Investigational Site

Benevento, Campania 82100

0 studies enrolling now · 6 studies all time

What they study most

Arthritis, Rheumatoid, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Pulmonary Disease, Chronic Obstructive, Thrombocytopaenia, Vomiting

Studies at this site

• A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed